InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,127.79
(
1.26%
)
US TECH 100
17,442.00
(
2.14%
)
Dow Jones
38,675.68
(
1.18%
)
Brent Oil
82.77
(
0.00%
)
Bitcoin
62,847.19
(
-0.07%
)
Post# of 438
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

DanWebzster

Send PM Follow Ignore
Followers 10
Posts 1060
Boards Moderated 2
Alias Born 09/04/2000

DanWebzster

Member Level

Re: DanWebzster post# 93

Sunday, 04/08/2018 10:05:07 AM

Sunday, April 08, 2018 10:05:07 AM

Post# of 438
ICPT raised $250mn from a 4/4/18 stock offering

MC = $1.8Bn

Offering will not cover R&D thru EOY.

Ocaliva is presently approved for a cholestatic disease known as Primary Biliary Cholangitis (PBC). NASH is an inflammatory cholestatic disease.

presently enrolling Ph3 NASH & Ph2 Biliary Artresia
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up